In accordance with the differential methylation status of MXD3 in KIRP, hypermethylation in KIRP was positively associated with dysfunctional T-cell phenotypes but was associated with longer survival of kidney papillary carcinoma cohorts (Fig. 5C). Here, MXD3 is linked to papillary renal cell carcinoma.